Clinical Trial Update: A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for A166 in patients with HER2-positive unresectable or metastatic breast cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• A166

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Her 2 Positive Breast Cancer | Phase 2 | Status: RECRUITING